Clinical Trial Update: Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating intravenous tropisetron for modulation of central hypersensitivity in chronic musculoskeletal pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Drugs mentioned

• tropisetron (tropisetron)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Pain, Chronic Disease | Phase 2 | Status: COMPLETED